CYH
Community Health Systems Inc.
$2.84
+$0.04(+1.43%)
47
Overall
60
Value
45
Tech
36
Quality
Market Cap
$394.57M
Volume
441.10K
52W Range
$2.39 - $4.43
Target Price
$3.31
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $21.3B | $15.4B | $14.2B | $13.2B | $11.8B | $12.4B | $12.2B | $12.5B | $12.6B | $12.5B | ||
| Total Revenue | $18.4B | $15.4B | $14.2B | $13.2B | $11.8B | $12.4B | $12.2B | $12.5B | $12.6B | $12.5B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-3.0B | $-2.7B | $-2.4B | $2.2B | $7.4B | $7.3B | $7.3B | $2.0B | $1.9B | $1.9B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $18.3B | $12.7B | $11.8B | $11.1B | $4.4B | $5.1B | $4.9B | $10.5B | $10.7B | $10.6B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $17.3B | $12.5B | $10.9B | $10.2B | $9.3B | $9.0B | $4.2B | $9.1B | $9.8B | $9.5B | ||
| Research & Development | -- | -- | -- | -- | -- | -- | -- | -- | $486.0M | -- | ||
| Research Expense | -- | -- | -- | -- | -- | -- | -- | -- | $486.0M | -- | ||
| Selling, General & Administrative | $450.0M | $394.0M | $337.0M | $321.0M | $327.0M | -- | -- | -- | -- | $426.0M | ||
| General & Administrative Expenses | $450.0M | $394.0M | $337.0M | $321.0M | $327.0M | -- | -- | -- | -- | $426.0M | ||
| Salaries & Wages | $8.6B | $7.4B | $6.4B | $5.9B | $5.4B | $5.2B | $5.3B | $5.4B | $5.4B | $5.4B | ||
| Depreciation & Amortization | $1.1B | $861.0M | $700.0M | $608.0M | $558.0M | $540.0M | $534.0M | -- | -- | -- | ||
| Depreciation & Amortization | $1.1B | $861.0M | $700.0M | $608.0M | $558.0M | $540.0M | $534.0M | -- | -- | -- | ||
| Amortization | $-709.0M | -- | -- | $4.3B | $4.2B | $4.2B | $4.2B | $4.0B | $3.8B | -- | ||
| Other Operating Expenses | $7.1B | $3.9B | $3.5B | $3.3B | $3.3B | $3.3B | $3.7B | $3.7B | $3.9B | $3.7B | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $1.1B | $214.0M | $887.0M | $650.0M | $1.1B | $1.4B | $821.0M | $957.0M | $542.0M | $1.5B | ||
| EBITDA | $-1.5B | $-2.8B | $-951.0M | $-381.0M | $2.0B | $1.9B | $1.7B | $2.0B | $1.1B | $2.0B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $7.0M | $1.0B | $888.0M | $860.0M | $830.0M | $860.0M | $870.0M | ||
| Interest Income Operating | -- | -- | -- | -- | -- | -- | -- | $2.0M | $3.0M | $2.0M | ||
| Intinc | $-962.0M | $-931.0M | $-976.0M | $-1.0B | $-1.0B | $-885.0M | $-858.0M | -- | $3.0M | -- | ||
| Net Non-Operating Interest Income/Expense | $-962.0M | $-931.0M | $-976.0M | $-1.0B | $-1.0B | $-885.0M | $-858.0M | $-830.0M | $-860.0M | $-870.0M | ||
| Gain on Sale of Securities | $28.0M | $3.0M | -- | $15.0M | $352.0M | $20.0M | $208.0M | -- | -- | -- | ||
| Other Income/Expense | $-107.0M | $24.0M | $-53.0M | $54.0M | $-327.0M | $18.0M | $488.0M | $-80.0M | $-35.0M | $-106.0M | ||
| Other Special Charges | $-30.0M | $-40.0M | $31.0M | $-54.0M | $317.0M | $-79.0M | $253.0M | $72.0M | $25.0M | $97.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $-125.0M | $-78.0M | $-80.0M | -- | $3.0M | -- | -- | -- | -- | ||
| Special Income Charges | $-1.9B | $-2.1B | $-679.0M | $-231.0M | $-48.0M | $-24.0M | $-71.0M | $87.0M | $-301.0M | $406.0M | ||
| Impairment of Capital Assets | $1.9B | $2.1B | $668.0M | $138.0M | $48.0M | $24.0M | $71.0M | $-87.0M | $301.0M | $-406.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-2.6B | $-3.7B | $-1.7B | $-989.0M | $1.5B | $1.4B | $1.2B | $1.5B | $577.0M | $1.6B | ||
| Pre-Tax Income | $-1.7B | $-2.8B | $-715.0M | $15.0M | $10.0M | $499.0M | $349.0M | $207.0M | $-283.0M | $724.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-104.0M | $-449.0M | $-11.0M | $160.0M | $-185.0M | $131.0M | $170.0M | $696.0M | $79.0M | $48.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-1.7B | $-2.5B | $-788.0M | $-675.0M | $511.0M | $230.0M | $46.0M | $-133.0M | $-516.0M | $509.0M | ||
| Net Income (Continuing Operations) | $-1.7B | $-2.5B | $-788.0M | $-675.0M | $511.0M | $230.0M | $179.0M | $16.0M | $-362.0M | $676.0M | ||
| Net Income (Discontinued Operations) | $-1.7B | $-2.5B | $-788.0M | $-675.0M | $511.0M | $230.0M | $46.0M | $-133.0M | $-516.0M | $509.0M | ||
| Net Income (Common Stockholders) | $-1.7B | $-2.5B | $-788.0M | $-677.0M | $511.0M | $230.0M | $46.0M | $-133.0M | $-516.0M | $509.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $310.8M | ||
| TOTALS | ||||||||||||
| Total Expenses | $14.2B | $9.8B | $8.6B | $12.3B | $11.2B | $11.1B | $11.5B | $11.1B | $11.8B | $11.4B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $110.7M | $111.8M | $112.7M | $113.7M | $115.5M | $126.8M | $128.8M | $130.4M | $132.1M | $133.6M | ||
| Average Shares Outstanding (Diluted) | $110.7M | $111.8M | $112.7M | $113.7M | $116.5M | $130.6M | $130.1M | $130.4M | $132.1M | $135.0M | ||
| Shares Outstanding | $113.8M | $114.6M | $116.2M | $117.9M | $129.6M | $132.1M | $134.7M | $136.7M | $138.9M | $138.6M | ||
| Basic EPS | $-15.54 | $-22 | $-6.99 | $-5.93 | $4.43 | $1.82 | $0.35 | $-1.02 | $-3.9 | $3.81 | ||
| Basic EPS (Continuing Operations) | $-15.41 | $-21.89 | $-6.99 | $-5.93 | $4.43 | $1.82 | $0.35 | $-1.02 | $-3.9 | $3.81 | ||
| Diluted EPS | $-15.54 | $-22 | $-6.99 | $-5.93 | $4.39 | $1.76 | $0.35 | $-1.02 | $-3.9 | $3.77 | ||
| Diluted EPS (Continuing Operations) | $-15.41 | $-21.89 | $-6.99 | $-5.93 | $4.39 | $1.76 | $0.35 | $-1.02 | $-3.9 | $3.77 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D Income | -- | -- | -- | -- | $10.0M | -- | -- | -- | -- | -- | ||
| Acquisition Expense | -- | -- | -- | $2.0M | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | $-0.13 | $-0.11 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | $-0.13 | $-0.11 | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $137.0M | $16.0M | $22.0M | $15.0M | $10.0M | $61.0M | $14.0M | $8.0M | $10.0M | $9.0M | ||
| Earnings From Equity Interest Net Of Tax | $137.0M | $16.0M | $22.0M | $15.0M | $10.0M | $61.0M | $14.0M | $8.0M | $10.0M | $9.0M | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | $-48.0M | $-24.0M | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $-15.0M | $-12.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-930.0M | $-852.0M | $-936.0M | $-1.0B | $-1.0B | $-778.0M | $-835.0M | -- | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | $16.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-95.0M | $-63.0M | $-84.0M | $-85.0M | $-96.0M | $-138.0M | $-133.0M | $-149.0M | $-154.0M | $-167.0M | ||
| Net Income Discontinuous Operations | $-15.0M | $-12.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $16.0M | $-31.0M | $11.0M | $93.0M | $50.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $450.0M | $394.0M | $337.0M | $321.0M | $327.0M | -- | -- | -- | -- | $426.0M | ||
| Other Impairment Of Capital Assets | $-1.9B | $-2.1B | $-668.0M | $138.0M | -- | -- | -- | -- | -- | -- | ||
| Other Taxes | -- | -- | -- | -- | -- | -- | -- | -- | $486.0M | -- | ||
| Realized Capital Gain | -- | -- | -- | -- | $10.0M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $450.0M | $394.0M | $337.0M | $321.0M | $327.0M | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | -- | -- | -- | -- | $505.0M | -- | -- | ||
| Restruct | -- | $-125.0M | $-78.0M | $-80.0M | -- | $3.0M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYH | $2.84 | +1.4% | 441.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Community Health Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW